Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;25(9):1138-46.
doi: 10.1038/eye.2011.122. Epub 2011 Jun 17.

AlphaCor artificial cornea: clinical outcome

N Jirásková  1 , P Rozsival, M Burova, M Kalfertova
Affiliations
Review

AlphaCor artificial cornea: clinical outcome

N Jirásková et al. Eye (Lond). 2011 Sep.

Abstract

Purpose: The purpose of this study was to describe the long-term results of AlphaCor implantations, and to evaluate the main complications and risk factors.

Methods: Retrospective analysis of preoperative and follow-up data from 15 AlphaCor implantations. Analysis of outcomes, trends, and associations was performed and compared with data from published clinical trials and a literature review.

Results: The survival rate of the device at 1, 2, and 3 years was 87%, 58%, and 42%, respectively. Postoperative visual acuity ranged from hand movement to 0.8. The most significant complications were stromal melt (nine cases), optic deposition (three eyes), and retroprosthetic membrane formation (three eyes). The most common device-unrelated complication was trauma (three patients). All complications were managed without loss of the eye.

Conclusion: AlphaCor provides a treatment option for patients with corneal blindness in which a donor tissue graft would not succeed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient 4 before stage I AlphaCor implantation.
Figure 2
Figure 2
Patient 12 before stage I AlphaCor implantation.
Figure 3
Figure 3
Patient 8 before cataract surgery at 18 months after stage II AlphaCor implantation.
Figure 4
Figure 4
Patient 8 after cataract surgery at 18 months after stage II AlphaCor implantation.
Figure 5
Figure 5
Stromal melting in patient 5.
Figure 6
Figure 6
Stromal melting in patient 12.
Figure 7
Figure 7
Optic deposits in patient 1.
Figure 8
Figure 8
Penetrating injury in patient 9.
See this image and copyright information in PMC

References

    1. Hicks CR, Crawford GJ. Indications and technique: AlphaCor artificial cornea. Tech Ophthalmol. 2003;1:151–155.
    1. Hicks CR, Crawford GJ, Dart JK, Grabner G, Holland EJ, Stulting RD, et al. AlphaCor clinical outcomes. Cornea. 2006;25:1034–1042. - PubMed
    1. Chirila TV, Vijayasekaran S, Horne R, Chen YC, Dalton PD, Constable IJ, et al. Interpenetrating polymer network (IPN) as a permanent joint between the elements of a new type of artificial cornea. J Biomed Mater Res. 1994;28:745–753. - PubMed
    1. Hicks CR, Crawford GJ, Tan DT, Snibson GR, Sutton GL, Downie N, et al. AlphaCor cases: comparative outcomes. Cornea. 2003;22:583–590. - PubMed
    1. Chirila TV, Thompson-Wallis DE, Crawford GJ, Constable IJ, Vijayasekaran S. Production of neocollagen by cells invading hydrogel sponges implanted in the rabbit cornea. Graefes Arch Clin Exp Ophthalmol. 1996;234:193–198. - PubMed

Publication types

Substances